Product Safety Recalls

Product Recall Tracker

TREPROSTINIL Recall D-0429-2024

Description: Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01

TREPROSTINIL Recall D-0429-2024 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0429-2024
Event ID94166
BrandTREPROSTINIL
Generic NameTREPROSTINIL
ManufacturerTREPROSTINIL
Original Package?1
Active SubstanceTREPROSTINIL
Drug RouteINTRAVENOUS
DistributionNationwide in the USA
Quantity466 vials
Recall ReasonPresence of Particulate Matter.
Drug ClassificationClass I
Drug Code Info20240403
Product NDC42023-206 42023-209 42023-208
Product NUIN0000175416 M0017817 N0000009909
Pharma Class (PE)Vasodilation [PE]
Pharma Class (EPC)Prostacycline Vasodilator [EPC]
Pharma Class (CS)Prostaglandins I [CS]
Recall Initiation Date20240304
Report Date20240403
Classification Date20240328
Address870 Parkdale Rd
Rochester, MI 48307-1740
United States
Recalling FirmPar Sterile Products LLC
Initial Notification Letter
Unique Ingredient IdentifierRUM6K67ESG
Drug Application NumberANDA209382
Structured Product Labeling (SPL ID)1798515a-9b6d-4718-b259-8f893c14b904
Structured Product Labeling (SPL Set ID)f251795d-aba6-4762-bdd9-477daab6e9a7
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.